Faculty of Science, University of Ontario Institute of Technology, Oshawa, Ontario, Canada.
Facuty of Health Sciences (Kinesiology), University of Ontario Institute of Technology, Oshawa, Ontario, Canada.
J Asthma. 2022 Dec;59(12):2520-2529. doi: 10.1080/02770903.2021.2018702. Epub 2021 Dec 28.
The purpose of this study was to determine whether high intensity interval training (HIIT) would lead to improvements in 1) maximal VO, V, V/VCO, and V/MVV, and/or 2) resting salivary concentrations of pro-inflammatory markers Interleukin (IL-8), interferon-gamma-inducible-protein (CXCL10/IP-10)) and anti-inflammatory marker IL-1 receptor antagonist (IL-1ra) in adults with well-controlled asthma compared to non-asthma controls.
Participants completed a maximal exercise test at the beginning (T1) and end (T2) of a 6-week HIIT intervention; saliva samples were obtained at the beginning and 30 min following the first (T1) and last (T2) exercise session.
Adults with asthma ( = 20; age: 21.4 ± 2.4 years) and non-asthma controls ( = 12; age: 22.5 ± 3.4 years) completed the intervention. VOmax increased from T1 to T2 in both groups (asthma T1 32.9 ± 8, T2 38.6 ± 8.2 ml/kg/min; controls T1 34.5 ± 11.8, T2 38.9 ± 12.3 ml/kg/min). Vmax also increased in both groups (asthma T1 97.7, T2 110.8 units, < 0.001, h = <0.04; control T1 106.3, T2 118.1, < 0.001, h 0.02). An increase in V/VCO (F(1, 10)=22.11, = 0.001) and V/MVV (F(1, 10) = 111.30, < 0.001) was observed in the control group; no differences were observed in the asthma group. No differences in IL-8 or IL-1ra were observed between groups. In the asthma group, resting salivary IP-10 concentrations significantly decreased from T1 (0.025 pg/ug protein) to T2 (0.015 pg/ug protein, = 0.039, h 0.3 (moderate effect)).
A 6-week HIIT intervention led to a similar increase in VOmax and Vmax in those with and without asthma, and a decrease in resting salivary IP-10 levels among adults with asthma.
本研究旨在确定高强度间歇训练(HIIT)是否会导致以下方面的改善:1)最大 VO₂、V、V/VCO₂ 和 V/MVV,和/或 2)成人哮喘患者休息时唾液中促炎标志物白细胞介素(IL)-8、干扰素γ诱导蛋白(CXCL10/IP-10)和抗炎标志物白细胞介素-1 受体拮抗剂(IL-1ra)的浓度。与非哮喘对照组相比。
参与者在 HIIT 干预的开始(T1)和结束(T2)时完成最大运动测试;在第一次(T1)和最后一次(T2)运动后 30 分钟,从开始时获取唾液样本。
哮喘组( = 20;年龄:21.4±2.4 岁)和非哮喘对照组( = 12;年龄:22.5±3.4 岁)完成了干预。两组 VOmax 均从 T1 增加到 T2(哮喘组 T1 为 32.9±8,T2 为 38.6±8.2ml/kg/min;对照组 T1 为 34.5±11.8,T2 为 38.9±12.3ml/kg/min)。两组 Vmax 均增加(哮喘组 T1 为 97.7,T2 为 110.8 单位, < 0.001,h=0.04;对照组 T1 为 106.3,T2 为 118.1, < 0.001,h=0.02)。对照组观察到 V/VCO₂(F(1,10)=22.11, = 0.001)和 V/MVV(F(1,10)=111.30, < 0.001)的增加;哮喘组无差异。两组间 IL-8 或 IL-1ra 无差异。在哮喘组中,休息时唾液 IP-10 浓度从 T1(0.025pg/ug 蛋白)降至 T2(0.015pg/ug 蛋白, = 0.039,h=0.3(中度效应))。
6 周 HIIT 干预可导致哮喘和非哮喘患者的 VOmax 和 Vmax 相似增加,并可降低哮喘患者休息时唾液 IP-10 水平。